Infection Control Unit, University Hospital Wuerzburg, Wuerzburg, Germany.
Department of Internal Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany.
J Med Virol. 2023 Jan;95(1):e28300. doi: 10.1002/jmv.28300. Epub 2022 Nov 18.
Against the background of the current COVID-19 infection dynamics with its rapid spread of SARS-CoV-2 variants of concern (VOC), the immunity and the vaccine prevention of healthcare workers (HCWs) against SARS-CoV-2 continues to be of high importance. This observational cross-section study assesses factors influencing the level of anti-SARS-CoV-2-spike IgG after SARS-CoV-2 infection or vaccination. One thousand seven hundred and fifty HCWs were recruited meeting the following inclusion criteria: age ≥18 years, PCR-confirmed SARS-CoV-2 infection convalescence and/or at least one dose of COVID-19 vaccination. anti-SARS-CoV-2-spike IgG titers were determined by SERION ELISA agile SARS-CoV-2 IgG. Mean anti-SARS-CoV-2-spike IgG levels increased significantly by number of COVID-19 vaccinations (92.2 BAU/ml for single, 140.9 BAU/ml for twice and 1144.3 BAU/ml for threefold vaccination). Hybrid COVID-19 immunized respondents (after infection and vaccination) had significantly higher antibody titers compared with convalescent only HCWs. Anti-SARS-CoV-2-spike IgG titers declined significantly with time after the second vaccination. Smoking and high age were associated with lower titers. Both recovered and vaccinated HCWs presented a predominantly good humoral immune response. Smoking and higher age limited the humoral SARS-CoV-2 immunity, adding to the risk of severe infections within this already health impaired collective.
在当前 COVID-19 感染动态下,SARS-CoV-2 变异株(VOC)迅速传播,医护人员(HCWs)对 SARS-CoV-2 的免疫力和疫苗预防仍然至关重要。本观察性横断面研究评估了影响 SARS-CoV-2 感染或接种疫苗后抗 SARS-CoV-2 刺突 IgG 水平的因素。本研究共招募了 1750 名符合以下纳入标准的 HCWs:年龄≥18 岁,PCR 确诊的 SARS-CoV-2 感染恢复期和/或至少接种一剂 COVID-19 疫苗。通过 SERION ELISA agile SARS-CoV-2 IgG 测定抗 SARS-CoV-2 刺突 IgG 滴度。抗 SARS-CoV-2 刺突 IgG 水平随着 COVID-19 疫苗接种次数的增加而显著增加(单剂为 92.2 BAU/ml,双剂为 140.9 BAU/ml,三剂为 1144.3 BAU/ml)。与仅恢复期的 HCWs 相比,混合 COVID-19 免疫的应答者(感染和接种疫苗后)具有更高的抗体滴度。第二次接种后,抗 SARS-CoV-2 刺突 IgG 滴度随时间显著下降。吸烟和高龄与较低的滴度相关。已康复和接种疫苗的 HCWs 均表现出良好的体液免疫反应。吸烟和高龄限制了 SARS-CoV-2 的体液免疫,增加了这个已经健康受损的人群中发生严重感染的风险。